Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae - PubMed (original) (raw)

Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae

J E Alexander et al. Infect Immun. 1994 Dec.

Abstract

Pneumolysin is the thiol-activated cytolysin produced by Streptococcus pneumoniae. Mice were immunized with a genetically engineered toxoid version of pneumolysin, which was derived from a serotype 2 pneumococcus. The toxoid carried the mutation Trp-433-->Phe. Alum was used as the adjuvant. Immunized mice had significantly increased levels of anti-pneumolysin antibodies, principally immunoglobulin G1. Mice were challenged intraperitoneally or intranasally with 12 strains covering capsular serotypes 1 to 6, 7F, 8, and 18C. Following challenge, the survival rate and/or the time of death of nonsurvivors (survival time) was significantly greater than that of sham-immunized mice for all nine serotypes. However, differences in the degree of protection were noted between different strains. The route of challenge also appeared to influence the degree of protection. Nevertheless, the significant, albeit in some cases partial, protection provided against all nine pneumococcal serotypes supports the conclusion that pneumolysin toxoids warrant consideration for inclusion in a human vaccine.

PubMed Disclaimer

Cited by

Distribution and genetic diversity of the ABC transporter lipoproteins PiuA and PiaA within Streptococcus pneumoniae and related streptococci.
Whalan RH, Funnell SG, Bowler LD, Hudson MJ, Robinson A, Dowson CG. Whalan RH, et al. J Bacteriol. 2006 Feb;188(3):1031-8. doi: 10.1128/JB.188.3.1031-1038.2006. J Bacteriol. 2006. PMID: 16428407 Free PMC article.
Pneumococcal vaccination and revaccination of older adults.
Artz AS, Ershler WB, Longo DL. Artz AS, et al. Clin Microbiol Rev. 2003 Apr;16(2):308-18. doi: 10.1128/CMR.16.2.308-318.2003. Clin Microbiol Rev. 2003. PMID: 12692100 Free PMC article. Review.
Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin.
García-Suárez Mdel M, Cima-Cabal MD, Flórez N, García P, Cernuda-Cernuda R, Astudillo A, Vázquez F, De los Toyos JR, Méndez FJ. García-Suárez Mdel M, et al. Infect Immun. 2004 Aug;72(8):4534-40. doi: 10.1128/IAI.72.8.4534-4540.2004. Infect Immun. 2004. PMID: 15271913 Free PMC article.
Monoclonal antibodies that recognize a common pneumococcal protein with similarities to streptococcal group A surface glyceraldehyde-3-phosphate dehydrogenase.
Kolberg J, Sletten K. Kolberg J, et al. Infect Immun. 1996 Sep;64(9):3544-7. doi: 10.1128/iai.64.9.3544-3547.1996. Infect Immun. 1996. PMID: 8751897 Free PMC article.
A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media.
Rosch JW, Iverson AR, Humann J, Mann B, Gao G, Vogel P, Mina M, Murrah KA, Perez AC, Edward Swords W, Tuomanen EI, McCullers JA. Rosch JW, et al. EMBO Mol Med. 2014 Jan;6(1):141-54. doi: 10.1002/emmm.201202150. EMBO Mol Med. 2014. PMID: 24408968 Free PMC article.

References

1. Rev Infect Dis. 1981 Mar-Apr;3 Suppl:S1-17 - PubMed
1. Annu Rev Microbiol. 1993;47:89-115 - PubMed
1. J Infect Dis. 1983 Jul;148(1):131-7 - PubMed
1. J Infect Dis. 1983 Dec;148(6):1136-59 - PubMed
1. J Clin Microbiol. 1987 Feb;25(2):222-5 - PubMed

Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae - PubMed (original) (raw)